Opportunities in Stem Cell Research and Commercialization - Where Regulatory and Ethical Issues are Explained in the Usage of Stem Cell Research.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c35585) has announced the addition of Opportunities in Stem Cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. Research and Commercialization: Technology Advances, Regulatory Impact and Key Players to their offering. Stem cell transplants are routinely used to treat patients with cancers and other disorders of the blood and the immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. and may hold the key to repairing or replacing tissue cells damaged in many devastating dev·as·tate tr.v. dev·as·tat·ed, dev·as·tat·ing, dev·as·tates 1. To lay waste; destroy. 2. To overwhelm; confound; stun: was devastated by the rude remark. diseases. Thus, proven and potential clinical benefit underpins the vast interest in stem cell research. Stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young have both the capacity to self-renew (by cell division) and differentiate into mature, specialized cells. Differentiation describes a process of development with an increase in the level of organisation or complexity of a cell, accompanied with a more specialized function. During differentiation, certain genes become activated and other genes become inactivated inactivated rendered inactive; the activity is destroyed. inactivated viruses treated so that they are no longer able to produce evidence of growth or damaging effect on tissue. in an intricately regulated fashion. As a result, a differentiated cell develops specific structures and performs certain functions. Key features --Growth forecasts for stem cell market sub-sectors to 2010. --Examination of proprietary technologies and company strategies shaping the market for adult, embryonic and fetal stem cell products. --Discussion of opportunities arising out of advances in hematopoietic stem cell transplantation hematopoietic stem cell transplantation Hematology A therapy in which defective hematopoietic cells are replaced with normal BM cells after chemotherapy and/or RT Indications AML, breast CA, CML, germ cell tumors, lymphoma, myelodysplastic syndrome, myeloma, . --Analysis of global regulatory issues which are dictating where and how embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. research is being done. Key findings --The market for stem cell products and services is forecast to grow almost three-fold from $24.6 billion in 2005 to $68.9 billion in 2010. --During the years 1980-2005, over 2,000 US patents claiming stem cell technologies and applications relevant to healthcare were published; the annual publication rate accelerated sharply in 2002. --The proportion of stem cell patents claiming applications in hematology decreased after 1999, while the proportion of patents claiming applications in neurology, type 1 diabetes type 1 diabetes n. See diabetes mellitus. , cardiology and drug screening increased. --Over 100 companies with proprietary human adult stem cell Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body technologies and products have been identified. Executive Summary Introduction to stem cells Regulatory and ethical issues Technologies and strategies Market analysis Adult stem cell programs Embryonic and fetal stem cell programs Patents in stem cell research Trends and opportunities Chapters are as follows:- Chapter 1 Introduction to stem cells Chapter 2 Regulatory and ethical issues Chapter 3 Technologies and strategies Chapter 4 Market analysis Chapter 5 Adult stem cell programs Chapter 6 Embryonic and fetal stem cell programs Chapter 7 Patents in stem cell research Chapter 8 Trends and opportunities Chapter 9 Appendix List of Figures List of Tables For more information visit http://www.researchandmarkets.com/reports/c35585 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion